Two targets hit, the third window still open
HSBC Holdings at week 7 of the buy signal: 2 out of 3 model targets already hit, stop at breakeven, signal strength at 64 out of 100. The next management window is next week.
GSK plc at week 3 of sell signal: minimal strength and bottom of the ranking
GSK plc carries its sell signal into week 3 with a strength of just 2 out of 100, ranking near the bottom of the EU-UK sell list. The quality band flags trading as not recommended: opening a short position carries elevated risk per our model.
Three targets hit, the stop protects the gain: the trader decides from here
Glencore is at week 24 of a buy signal opened in late 2024. All 3 statistical targets were hit by week 7. The structural stop has trailed the rally and now protects the accumulated gain.
Two targets hit, the third still open: trade management is the game now
At week 7, the European basic resources ETF has already hit 2 out of 3 roadmap targets. The stop is at breakeven, risk is zeroed out. The next management window arrives this week.
iShares Health Care Europe: three observation weeks, no confirmation
Sell signal on iShares STOXX Europe 600 Health Care ETF in its 4th week, not confirmed by the market. Signal strength at 2 out of 100, trading not recommended per our model. We prefer to wait.
iShares STOXX Europe 600 Technology: two windows hit, third in sight
BUY at week 6 on European technology: 2 management windows already hit, signal strength at 79 out of 100, price hugging all-time highs. The model suggests trimming, not adding.